Evidence map›Paper›PMID 34713221›Full record

ReviewFrontiers in genome editing2020

Gene Correction of Point Mutations Using PolyPurine Reverse Hoogsteen Hairpins Technology.

Alex J Félix, Anna Solé, Véronique Noé, Carlos J Ciudad

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in genome editing, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alex J FélixDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, and Institute for Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain.
Anna SoléDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, and Institute for Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain.
Véronique NoéDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, and Institute for Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain.
Carlos J CiudadDepartment of Biochemistry and Physiology, School of Pharmacy and Food Sciences, and Institute for Nanoscience and Nanotechnology (IN2UB), University of Barcelona, Barcelona, Spain.
Institut de Nanociència i Nanotecnologia de la Universitat de BarcelonaUniversitat de Barcelona · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Monogenic disorders are often the result of single point mutations in specific genes, leading to the production of non-functional proteins. Different blood disorders such as ß-thalassemia, sickle cell disease, hereditary spherocytosis, Fanconi anemia, and Hemophilia A and B are usually caused by point mutations. Gene editing tools including TALENs, ZFNs, or CRISPR/Cas platforms have been developed to correct mutations responsible for different diseases. However, alternative molecular tools such as triplex-forming oligonucleotides and their derivatives (e.g., peptide nucleic acids), not relying on nuclease activity, have also demonstrated their ability to correct mutations in the DNA. Here, we review the Repair-PolyPurine Reverse Hoogsteen hairpins (PPRHs) technology, which can represent an alternative gene editing tool within this field. Repair-PPRHs are non-modified single-stranded DNA molecules formed by two polypurine mirror repeat sequences linked by a five-thymidine bridge, followed by an extended sequence at one end of the molecule which is homologous to the DNA sequence to be repaired but containing the corrected nucleotide. The two polypurine arms of the PPRH are bound by intramolecular reverse-Hoogsteen bonds between the purines, thus forming a hairpin structure. This hairpin core binds to polypyrimidine tracts located relatively near the target mutation in the dsDNA in a sequence-specific manner by Watson-Crick bonds, thus producing a triplex structure which stimulates recombination. This technology has been successfully employed to repair a collection of mutants of the

Indexed as

APRTDHFRgene-editingmutationrepair-PPRHtriplex

Identifiers

PMID34713221
PMCPMC8525393
OpenAlexW3097686887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.